Deficiency in type I IFN production by pDCs might lead to persistent viral infections [93,94] or tumor growth due to the lack of IFN-induced anti-tumor activity [95,96], whereas pDC overactivation can result in the development of autoimmune pathologies associated with a high IFN signature [97,98]. This evidence concerns the gene IFNA1 and viral infectious disease.